Table 1.
Clinical Findings in Patients with EM According to Isolate Genotype
| Species and genotype | Total isolates | EM |
No. of patients with hematogenous dissemination⁎ | No. of symptoms [median (range)]† | |
|---|---|---|---|---|---|
| Median size (cm) | Median duration (days) | ||||
| B. burgdorferi | 30 | 10 | 3 | 15 | 5.0 (0–20) |
| RST1 | 10 | 10 | 3 | 6 | 8.5 (3–11) |
| OspC type A | 10 | 10 | 3 | 6 | 8.5 (3–11) |
| RST2 | 10 | 12 | 4 | 6 | 1.5 (0–20) |
| OspC type F | 1 | 18 | 3 | 0 | 2.0 (2) |
| OspC type N | 2 | 14 | 6 | 1 | 0.5 (0–1) |
| OspC type K | 7 | 12 | 3 | 5 | 3.0 (0–20) |
| RST3 | 10 | 10 | 3 | 3 | 6.5 (0–10) |
| OspC type D | 1 | 8 | 7 | 1 | 0.0 (0) |
| OspC type E | 2 | 10 | 4 | 1 | 9.0 (8–10) |
| OspC type G | 2 | 12 | 4 | 0 | 4.5 (0–9) |
| OspC type I | 5 | 9 | 3 | 1 | 6.0 (2–9) |
⁎
Hematogenous dissemination in patients with EM was based on a positive PCR result in blood or multiple EM lesions.
†
The number of symptoms in patients with RST1 infection was significantly greater than in patients with RST2 infection (P = 0.01).